RxDoctor Payments Data

Bryan Lansford, MD

Otolaryngology · Jonesboro, ARNPI 1265498091

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,668 of the $2,615 with a category attached, or 63.8%. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 37.6% of the total. Reporting peaked in 2022 at $1,150 and has fallen 70.8% since, to $335 in 2025.

$2,615in general payments, 2019–2025

Across 61 payments — averaging $42.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$983
  • Merz North America, Inc.$389
  • Sanofi$291
  • GSK$284
  • Stryker$215
  • Regeneron Healthcare Solutions, Inc.$214
  • plus $239 from 5 others

What the payments were for

  • Travel & lodging$94736%
  • Food & beverage$1,66864%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,615 in reported general payments places this provider in the 80th percentile of 72 otolaryngology providers in Arkansas.

See all otolaryngology providers in Arkansas

Medicare billing

Part B allowed, 2024
$183,136
Medicare patients
415
Services billed
1,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$49,857
Dupixent SyringeDupilumab13$48,356
Pilocarpine Hcl87$8,563
SynthroidLevothyroxine Sodium50$3,046
Omeprazole175$2,236
Fluticasone Propionate184$1,900
Cevimeline Hcl22$1,775
Tobramycin-DexamethasoneTobramycin/Dexamethasone20$1,079
Ondansetron OdtOndansetron89$903
Ipratropium Bromide30$879
Azelastine Hcl23$744
Methylprednisolone91$711
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen77$605
Levothyroxine Sodium72$546
Levofloxacin73$430

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →